✦ LIBER ✦

Natural course of joint destruction and fluctuation of serum c1q levels in patients with rheumatoid arthritis

✍ Scribed by Takahiro Ochi; Rokuro Iwase; Kunio Yonemasu; Mitsuhiro Matsukawa; Minoru Yoneda; Masao Yukioka; Keiro Ono

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 581 KB
Volume: 31
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780310106

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical correlations with serum C1q lev

Clinical correlations with serum C1q levels in patients with rheumatoid arthritis

✍ Nancy J. Olsen; Edward Ho; Lev Barats 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB 👁 2 views

Association of baseline levels of urinar

Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis

✍ Patrick Garnero; Evelyne Gineyts; Stephan Christgau; Barbara Finck; Pierre D Del 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Correlation of Serum Interleukin-6 Level

Correlation of Serum Interleukin-6 Levels with Joint Involvement and Thrombocytosis in Systemic Juvenile Rheumatoid Arthritis

✍ Fabrizio de Benedetti; Margherita Massa; Piera Robbioni; Angelo Ravelli; Giusepp 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB 👁 2 views

Serum macrophage inhibitory cytokine 1 i

Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: A potential marker of erosive joint destruction

✍ David A. Brown; John Moore; Heiko Johnen; Tom J. Smeets; Asne R. Bauskin; Tamara 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 2 views

## Abstract ## Objective The transforming growth factor β superfamily member macrophage inhibitory cytokine 1 (MIC‐1) is expressed upon macrophage activation, regulated by the p53 pathway, and linked to clinical events in atherosclerosis and cancer. Since rheumatoid arthritis (RA) shares similar e

D-penicillamine in patients with rheumat

D-penicillamine in patients with rheumatoid arthritis serum levels, pharmacokinetic aspects, and correlation with clinical course and side effects

✍ A. O. Muijsers; R. J. Van De Stadt; A. M. A. Henrichs; H. J. W. Ament; J. K. Van 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 666 KB

After administration of D-penicillamine to patients with rheumatoid arthritis, measurements of serum level and urinary excretion showed half-life times of 1.6 hours in the rapid phase and 4-6 days in the slow phase. The latter evidence suggests that tissue pooling occurs. With a dosage of 750 mglday

Soluble interleukin-2 receptor: Elevated

Soluble interleukin-2 receptor: Elevated levels in serum and synovial fluid of patients with rheumatoid arthritis

✍ A. B. Carpenter; C. H. Eisenbeis; Jr.; S. Carrabis; M. C. Brown; S. H. Ip 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 452 KB

Soluble interleukin-2 receptor (sll-2R) levels were quantitated in the seum and synovial fluid (SF) of patients with rheumatoid arthritis (RA) and degenerative joint disease (DJD). A sandwich immunoassay, employing two monoclonal antiodies against distinct epitopes on the lL-2R, was utilized for mea